期刊文献+

应用彩色多普勒超声探讨肝癌患者门静脉逆流与肝癌肝内转移的相关性 被引量:2

THE RELATIONSHIP BETWEEN THE COUNTERCURRENT OF PORTAL VEIN AND INTRAHEPATIC CANCER METASTASIS IN PATIENTS WITH HEPATIC CARCINOMA UNDER COLOR DOPPLER FLOW IMAGING
下载PDF
导出
摘要 为探讨肝癌患者门静脉逆流与肝癌肝内转移的关系 ,应用灰阶超声观测肝炎肝癌组、非肝炎肝癌组门静脉癌栓和癌肿肝内转移情况 ;彩色多普勒超声检测肝炎肝癌组、非肝炎肝癌组、肝硬化组与对照组门静脉 肝动脉瘘及门静脉逆流的发生率。结果显示 ,肝炎肝癌组门静脉逆流的发生率及门静脉癌栓、癌肿肝内转移发生率均高于非肝炎肝癌组 (P <0 .0 1) ;肝硬化组门静脉逆流的发生率高于对照组 (P <0 .0 1) ;肝炎肝癌组与非肝炎肝癌组肿块内及周围的门静脉 肝动脉瘘发生率无明显差别 (P >0 .0 5 )。 The present study was performed to investigate the relationship between the countercurrent of portal vein and intrahepatic cancerometastasis in patients with hepatic carcinoma under color Doppler flow imaging.To display the situation of portal carcinomatous thrombosis and intrahepatic cancerometastasis, two dimensional ultrasound was carried out in patients with hepatitis hepatocarcinoma and non hepatitis hepatocarcinoma. Also, color Doppler flow imaging was employed to examine the incidence of the pylic countercurrent and the portal vein hepatic artery fistula in four groups: hepatitis hepatocarcinoma group, non-hepatitis hepatocarcinoma group, hepatocirrhosis group and control group. The results showed that the incidences of portal carcinomatous thrombosis,intrahepatic cancerometastasis and the incidences of the countercurrent in portal vein were higher in hepatitis hepatocarcinoma group than those in non hepatitis hepatocarcinoma group ( P <0.01), but the incidence of the portal vein hepatic artery fistula was not markedly different between hepatitis hepatocarcinoma and non hepatitis hepatocarcinoma groups. The countercurrent of portal vein is an important factor in intrahepatic cancerometastasis in patients with hepatic carcinoma.
机构地区 济南军区总医院
出处 《解放军医学杂志》 CAS CSCD 北大核心 2001年第7期490-491,共2页 Medical Journal of Chinese People's Liberation Army
关键词 彩色多普勒 肝肿瘤 肿瘤转移 血液动力学 门静脉逆流 ultrasonography,Doppler,color liver neoplasm neoplasm metastasis hemodynamics
  • 相关文献

参考文献7

二级参考文献10

共引文献76

同被引文献32

  • 1杨冬华.肝癌的转移与复发[J].中华肝脏病杂志,2004,12(8):491-492. 被引量:14
  • 2JianGuan Xiao-PingChen HongZhu Shun-FengLuo BinCao LeiDing.Involvement of extracellular signal-regulated kinase/mitogenactivated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line[J].World Journal of Gastroenterology,2004,10(23):3522-3527. 被引量:15
  • 3李孟森,周升海.甲胎蛋白维持肝癌细胞恶性增生的作用机制[J].国外医学(肿瘤学分册),2003,30(6):456-459. 被引量:5
  • 4The Liver Cancer Study Group of Japan.The general rules for the clinical and pathological study of primary liver cancer.Tokyo:Kanehara,2000.32-39.
  • 5Nakashima O,Kojiro M.Recurrence of hepatocellular carcinoma:multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology.J Hepatobiliary Pancreat Surg,2001,8:404-409.
  • 6Tsuda H,Hirohashi S,Sakamoto M.The onset and progression of hepatocellular carcinoma (in Japanese).Oncologia,1990,23:35-39.
  • 7Nomoto S,Yamashita K,Koshikawa K,et al.Mitochondrial,dloop mution as clonal markers in multicentric hepatocellular carcinoma and plasma.Clin Cancer Res,2002,8:481-487.
  • 8Ngan H,Peh WC.Arteriovenous shunting in hepatocellular carcinoma:its prevalence and clinical significance.Clin Radiol,1997,52:36-40.
  • 9Hu J,Pi Z,Yu MY,et al.Obstruction jaundice caused by tumor emboli from hepatocellular carcinoma.Am Surg,1999,65:406-410.
  • 10Shiina S,Komatsu Y,Kawabe T,et al.Cholestatic hepatocellular carcinoma diagnosed by deposits of lipiodol and treated by combination of endoscopic retrograde biliary drainge and transcatheterarterial embolization.J Gastroenterol Hepatol,1992,7:154-156.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部